Olga Granaturova

Olga Granaturova is an accomplished pharma and biotech professional with over 25 years of experience. She has worked with top industry players including Pfizer, BMS, MDS, Merck & Co., and Evotec, where she is currently serving as the Vice President of Strategic Business Development. Her work spans the entire value chain from R&D to Commercial Launch, touching on multiple therapeutic areas such as Oncology, Neuroscience, Ophthalmology, and Antivirals. Olga has held various positions in her career including Co-Founder & Chief Business Officer at Parthenon Therapeutics, Founder at Brighter Ventures, Co-Founder & CEO at LUCIDITAI, and Founder & Managing Partner at LENUS Group, among others. She has also mentored startups, helping develop their ideas and inventions into companies. Olga has a diverse educational background, including a Master of Business Administration (M.B.A.) from TRIUM Global Executive MBA, HEC Paris, NYU Stern School of Business, and The London School of Economics and Political Science (LSE). She also studied Pharmaceutical Sciences at the University at Buffalo. Her expertise includes preclinical and clinical development, corporate development, business development, oversight of joint ventures and partnerships, leading cross-functional/cross-cultural teams, negotiations with federal regulatory agencies, and developing strategies leading to commercialization worldwide.